Kura Oncology KURA
NASDAQ KURA
$10.65 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kura Oncology (KURA) Long-Term Debt Repayments (2018 - 2021)

Updated

Kura Oncology's Long-Term Debt Repayments came in at $7.25 million for FY2021, compared with $250,000 in FY2020.

Analysis

Kura Oncology (KURA) Long-Term Debt Repayments (2018 - 2021) Analysis & Trends

Going back to FY2017, Kura Oncology's Long-Term Debt Repayments data covers 4 years.

  • Long-Term Debt Repayments carries a four-year compound annual growth rate of 114.3% (FY2017 to FY2021).
  • Per Business Quant, earlier years put Long-Term Debt Repayments at $250,000 in FY2020, $1.25 million in FY2018 (+263.4%) and $344,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 2.00 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -2.45 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 17.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Kura Oncology 947.36 Mn 947.36 Mn 20.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 6.50 Mn
Mar 31, 2021 750,000.00
Dec 31, 2018 250,000.00
Sep 30, 2018 750,000.00
API Access

Kura Oncology Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=KURA&period=max&api_key=YOUR_API_KEY